Financials
Financial year 2025
Gross margin
€ -158,581
Profit
Caution€ -161,100
Debts
Low€ 136,496
Taikun Pharmaceutical Technology from Gent, company number BE1007641938, closed financial year 2025 with a result of € -161,100 after tax. For that financial year Taikun Pharmaceutical Technology recorded a gross margin of € -158,581 and equity of € 138,900. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.
What happened at Taikun Pharmaceutical Technology?
What happened at Taikun Pharmaceutical Technology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 161,100. Source: NBB ↗
- New establishment in Wevelgem. KBO
- New establishment in Gent. KBO
- Tom De Gres became a director. NBB
- Jun Ji became a director. NBB
- Yuzhu Feng became a director. NBB
- Zhennyu Shi became a director. NBB
- Hubert Sigiez became a director. NBB
A new publication or filing at Taikun Pharmaceutical Technology? We notify you, reason included.
Follow Taikun Pharmaceutical TechnologyNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Taikun Pharmaceutical Technology are Tom De Gres, Jun Ji, Yuzhu Feng, Zhennyu Shi and Hubert Sigiez. The same people are also behind Ace, SAVERDE, SOLVUS, International Platform for Art Research & Conservation and FoodCheck.
Establishments
Establishment units
Physical locations of this company
Frieda Saeysstraat 3
9052 Gent
Vliegveld 13
8560 Wevelgem
Active since 27 April 2026
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1007.641.938
- VAT number
- BE 1007.641.938
- Registered office
- Frieda Saeysstraat 3, 9052 Gent
- Names & denominations
- Taikun Pharmaceutical Technology
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 March 2024
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van farmaceutische grondstoffen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied